Used for:
Short-term procedures (e.g., fracture reductions, dislocations, wound repair)
Patients at high risk of bronchospasm (e.g., asthma)
Hemodynamically unstable patients
Mechanism:
Achieves sedation through N-methyl-D-aspartate (NDMA) receptor antagonism.
Creates a dissociative state and produces analgesia through partial agonism of opiate mu-receptors.
CNS Effects:
Increases cerebral oxygen consumption and blood flow: Unclear if ketamine increases intracranial pressure.
Cardiovascular (CV) Effects:
Increases BP and HR: Induces central release of endogenous catecholamines.
Respiratory Effects:
Bronchodilation: Upper airway skeletal muscle tone maintained, less prone to airway obstruction; laryngeal reflexes intact, less risk of aspiration
Decreases TV and RR: Inhibits CNS sensitivity to hypercapnia.
Adverse Effects:
PONV, dizziness
Restlessness and agitation common on emergence
Contraindications:
Patients with low tolerance to acute increases in BP (e.g., ischemic heart disease, aortic dissection, known aneurysms)
Patients at risk of acutely increased intracranial pressure